Related Experiment Video
Updated: Jun 21, 2026
15:04
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
A conditional synergy index to assess biological interaction
1Bremen Institute for Prevention Research and Social Medicine, University of Bremen, Linzer Strasse 10, 28359, Bremen, Germany. foraita@bips.uni-bremen.de
European Journal of Epidemiology
|August 12, 2009
Summary
This study introduces a new method, the conditional synergy index (CSI), to detect biological gene-gene interactions in complex diseases. The CSI captures synergistic and antagonistic relationships on the penetrance scale, offering a more biologically relevant measure than traditional statistical approaches.
Area of Science:
- Genetics
- Epidemiology
- Biostatistics
Background:
- Identifying gene-gene interactions is vital for understanding complex diseases.
- Current statistical definitions of gene-gene interactions may not accurately reflect biological relationships.
- A novel approach is needed to capture the biological interplay between genes.
Purpose of the Study:
- To propose and develop a new method for detecting gene-gene interactions based on biological concepts of synergy and antagonism.
- To introduce the conditional synergy index (CSI) for quantifying gene-gene interactions on the penetrance scale.
- To evaluate the performance of the CSI and compare it with existing epidemiological interaction measures.
Main Methods:
- Developed the conditional synergy index (CSI) for two-locus disease models using cohort data.
- Dichotomized genotypes into risk and non-risk categories, without assuming linkage equilibrium.
- Investigated CSI performance and compared it with Rothman's synergy index (S) and attributable proportion due to interaction (AP).
Main Results:
- The conditional synergy index (CSI) effectively quantifies biological gene-gene interactions on the penetrance scale.
- The CSI is applicable to two-locus models and cohort data, even without assuming linkage equilibrium.
- Performance evaluation demonstrated the utility of the CSI and its estimator in practical examples.
Conclusions:
- The conditional synergy index (CSI) provides a biologically meaningful measure of gene-gene interactions for complex diseases.
- This new index offers an alternative to traditional statistical measures, enhancing biological interpretability.
- The CSI and its estimator are valuable tools for genetic and epidemiological research.
Related Concept Videos
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:13Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...